Skin disorders associated with the COVID-19 pandemic: A review

Jennifer Akl, Jessica El-Kehdy, Antoine Salloum, Anthony Benedetto, Paula Karam, Jennifer Akl, Jessica El-Kehdy, Antoine Salloum, Anthony Benedetto, Paula Karam

Abstract

Introduction: In December 2019, a new coronavirus has emerged out of China, the SARS-CoV-2 virus, causing a disease known as COVID-19, which steadily has progressed into a pandemic. This coronavirus affects many organs, including the skin, whose manifestations are a consequence of the disease itself, as well as the preventative measures taken to avoid the infection. This paper reviews the cutaneous manifestations which currently have been encountered during this pandemic.

Methods: A search was conducted on PubMed, and all relevant articles were included.

Results: The results show the occurrence of many cutaneous findings, ranging from those related to the infection itself and to various dermatitides related to the use of personal protective equipment (PPE) utilized by healthcare workers while attending to infected patients.

Discussion: Recognizing these findings is important for the accurate diagnosis of those infected with COVID-19 as well as the prompt treatment of the side effects caused by PPE that might further impair the effectiveness of healthcare workers.

Keywords: COVID; cutaneous; pandemic; rash; skin.

Conflict of interest statement

None.

© 2021 Wiley Periodicals LLC.

Figures

FIGURE 1
FIGURE 1
Itchy urticariform rash that appeared in a middle‐aged woman 16 days after COVID symptom onset. SARS‐CoV‐2 infection was confirmed by PCR
FIGURE 2
FIGURE 2
Itchy urticariform rash appearing in a young man during the first week of COVID infection, confirmed by PCR. Rash spontaneously resolved around a week later. Courtesy of Dr. Omar Zmerli
FIGURE 3
FIGURE 3
Petechial and purpuric patches and plaques over the bilateral lower extremities, overlying the shins and dorsa of feet, appearing 2 days after onset of fever in a middle‐aged man, found to have COVID, confirmed by PCR. Lesions were asymptomatic. Resolved within 5 days after treatment with systemic corticosteroids (for COVID). Courtesy of Dr. Karam Karam
FIGURE 4
FIGURE 4
Purpuric patches over the bilateral medial aspects of the feet, overlying the medial malleoli, appearing 2 days after onset of fever in a middle‐aged man with PCR‐confirmed COVID. Courtesy of Dr. Karam Karam
FIGURE 5
FIGURE 5
Purpuric patches and plaques over right lower extremity, with a reticular pattern, overlying the posterolateral aspect of the calf. The rash appeared 2 days after onset of fever in a middle‐aged man, found to have PCR‐confirmed COVID. Courtesy of Dr. Karam Karam
FIGURE 6
FIGURE 6
Excoriations secondary to severe pruritus over left lower extremity of a COVID‐positive (confirmed by PCR) young woman. Pruritus started a few days after onset of fever, cough, and myalgias. No new medications had been started prior to onset of pruritus. Courtesy of Dr Maya Habre
FIGURE 7
FIGURE 7
Excoriations over the right elbow and forearm of a COVID‐positive young woman. Pruritus started a few days after onset of systemic symptoms. Courtesy of Dr Maya Habre
FIGURE 8
FIGURE 8
Severe pruritus leading to excoriations over the left upper extremity of a young woman with symptomatic, PCR‐confirmed woman. These excoriations are distributed over the arm and forearm. Courtesy of Dr Maya Habre
FIGURE 9
FIGURE 9
Excoriated papules over the right leg and shin of a young COVID‐positive patient few days after onset of fever, chills, and myalgias. Courtesy of Dr Maya Habre.
FIGURE 10
FIGURE 10
Excoriations over the medial aspect of the right leg of a COVID‐positive, symptomatic, young woman. Courtesy of Dr Maya Habre

References

    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol JEADV. 2020;. 10.1111/jdv.16387.
    1. Zheng Y, Lai W. Dermatology staff participate in fight against Covid‐19 in China. J Eur Acad Dermatol Venereol JEADV. 2020;34(5). 10.1111/jdv.16390
    1. Darlenski R, Tsankov N. Covid‐19 pandemic and the skin ‐ What should dermatologists know? Clin Dermatol. 2020;38(6):785‐787. 10.1016/j.clindermatol.2020.03.012
    1. Tammaro A, Adebanjo G, Parisella FR, Pezzuto A, Rello J. Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020;34(7). 10.1111/jdv.16530
    1. Su C‐J, Lee C‐H. Viral exanthem in COVID‐19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol JEADV. 2020;34(6). 10.1111/jdv.16469
    1. de Masson A , Bouaziz J‐D, Sulimovic L, et al. Chilblains is a common cutaneous finding during the COVID‐19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667‐670. 10.1016/j.jaad.2020.04.161
    1. Kanitakis J, Lesort C, Danset M, Jullien D. Chilblain‐like acral lesions during the COVID‐19 pandemic (“COVID toes”): histologic, immunofluorescence and immunohistochemical study of 17 cases. J Am Acad Dermatol. 2020;83(3):870‐875. 10.1016/j.jaad.2020.05.145
    1. López‐Robles J, de la Hera I , Pardo J, Martínez J, Cutillas‐Marco E. Chilblain‐like lesions: a case series of 41 patients during the COVID‐19 pandemic. Clin Exp Dermatol. 2020;45(7):891‐892. 10.1111/ced.14275
    1. Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID‐19) infection‐induced chilblains: A case report with histopathologic findings. JAAD Case Rep. 2020;6(6):489‐492. 10.1016/j.jdcr.2020.04.011
    1. Kerber AA, Soma DB, Youssef MJ. Chilblains‐like dermatologic manifestation of COVID‐19 diagnosed by serology via multidisciplinary virtual care. Int J Dermatol. 2020;59(8):1024‐1025. 10.1111/ijd.14974
    1. Recalcati S, Barbagallo T, Frasin LA, et al. Acral cutaneous lesions in the Time of COVID‐19. J Eur Acad Dermatol Venereol JEADV. 2020;34(8). 10.1111/jdv.16533
    1. Freeman EE, McMahon DE, Lipoff JB, et al. Pernio‐like skin lesions associated with COVID‐19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486‐492. 10.1016/j.jaad.2020.05.109
    1. Alramthan A, Aldaraji W. Two cases of COVID‐19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. 2020;45(6):746‐748. 10.1111/ced.14243
    1. El Hachem M, Diociaiuti A, Concato C, et al. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain‐like lesions: lights and shadows on the relationship with COVID‐19 infection. J Eur Acad Dermatol Venereol JEADV. 2020;34(11):2620‐2629. 10.1111/jdv.16682
    1. Piccolo V, Neri I, Filippeschi C, et al. Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol JEADV. 2020;34(7):e291‐e293. 10.1111/jdv.16526
    1. Andina D, Noguera‐Morel L, Bascuas‐Arribas M, et al. Chilblains in children in the setting of COVID‐19 pandemic. Pediatr Dermatol. 2020;37(3):406‐411. 10.1111/pde.14215
    1. Colmenero I, Santonja C, Alonso‐Riaño M, et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183(4):729‐737. 10.1111/bjd.19327
    1. Locatelli AG, Robustelli Test E, Vezzoli P, et al. Histologic features of long‐lasting chilblain‐like lesions in a paediatric COVID‐19 patient. J Eur Acad Dermatol Venereol JEADV. 2020;34(8):e365‐e368. 10.1111/jdv.16617.
    1. Landa N, Mendieta‐Eckert M, Fonda‐Pascual P, Aguirre T. Chilblain‐like lesions on feet and hands during the COVID‐19 Pandemic. Int J Dermatol. 2020;59(6):739‐743. 10.1111/ijd.14937
    1. Suarez‐Valle A, Fernandez‐Nieto D, Diaz‐Guimaraens B, Dominguez‐Santas M, Carretero I, Perez‐Garcia B. Acro‐ischemia in hospitalized COVID‐19 patients. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16592
    1. Tosti G, Barisani A, Queirolo P, et al. Skin signs resembling vascular acrosyndromes during the COVID‐19 outbreak in Italy. Clin Exp Dermatol. 2020. 10.1111/ced.14267
    1. Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC. Acro‐ischemia and COVID‐19 infection: clinical and histopathological features. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16687
    1. Reymundo A, Fernáldez‐Bernáldez A, Reolid A, et al. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. J Eur Acad Dermatol Venereol. 2020;34(12). 10.1111/jdv.16707
    1. Ahouach B, Harant S, Ullmer A, et al. Cutaneous lesions in a patient with COVID‐19: are they related? Br J Dermatol. 2020;183(2). 10.1111/bjd.19168
    1. Paolino G, Canti V, Mercuri SR, Rovere Querini P, Candiani M, Pasi F. Diffuse cutaneous manifestation in a new mother with COVID‐19 (SARS‐Cov‐2). Int J Dermatol. 2020;59(7):874‐875. 10.1111/ijd.14919
    1. Hunt M, Koziatek C. A Case of COVID‐19 pneumonia in a young male with full body rash as a presenting symptom. Clin Prac Cases Emerg Med. 2020;4(2). 10.5811/cpcem.2020.3.47349
    1. Najarian DJ. Morbilliform exanthem associated with COVID‐19. JAAD Case Rep. 2020;6(6):493‐494. 10.1016/j.jdcr.2020.04.015
    1. Rossi E, Lasagni C, Trakatelli M, Wertzberger Rowan S, Magnoni C. Acute maculopapular eruption in Covid‐19 patient: A case report. Dermatol Ther. 2020;33(6):e13812. 10.1111/dth.13812
    1. Malih N, Hajinasrollah G, Zare M, Taheri M. Unexpected presentation of COVID‐19 in a 38‐year‐old male patient: a case report. Case Rep Dermatol. 2020;12(2):124‐131. 10.1159/000509994
    1. Falkenhain López D, Sánchez‐Velázquez A, Ortiz de Frutos J. Maculopapular rash as initial manifestation of SRAS‐coronavirus‐2 infection. Med Clin Engl Ed. 2020;155(2):92. 10.1016/j.medcle.2020.04.008
    1. Gianotti R, Veraldi S, Recalcati S, et al. Cutaneous Clinico‐Pathological Findings in three COVID‐19‐Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Derm Venereol. 2020;100(8):adv00124‐adv132. 10.2340/00015555-3490
    1. Genovese G, Colonna C, Marzano AV. Varicella‐like exanthem associated with COVID‐19 in an 8‐year‐old girl: A diagnostic clue? Pediatr Dermatol. 2020;37(3):435‐436. 10.1111/pde.14201
    1. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella‐like exanthem as a specific COVID‐19–associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280‐285. 10.1016/j.jaad.2020.04.044
    1. Fernandez‐Nieto D, Ortega‐Quijano D, Jimenez‐Cauhe J, et al. Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020;45(7):872‐875. 10.1111/ced.14277
    1. Gaspari V, Neri I, Misciali C, Patrizi A. COVID‐19: how it can look on the skin. Clinical and pathological features in twenty COVID‐19 patients observed in Bologna, northeastern Italy. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16693
    1. Mahé A, Birckel E, Merklen C, et al. Histology of skin lesions establishes that the vesicular rash associated with COVID‐19 is not “varicella‐like”. J Eur Acad Dermatol Venereol JEADV. 2020;34(10):e559‐e561. 10.1111/jdv.16706
    1. van Damme C , Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16523
    1. Quintana‐Castanedo L, Feito‐Rodríguez M, Valero‐López I, Chiloeches‐Fernández C, Sendagorta‐Cudós E, Herranz‐Pinto P. Urticarial exanthem as early diagnostic clue for COVID‐19 infection. JAAD Case Rep. 2020;6(6):498‐499. 10.1016/j.jdcr.2020.04.026
    1. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatol Venereol JEADV. 2020;34(6):e244‐e245. 10.1111/jdv.16472
    1. Abasaeed Elhag SA, Ibrahim H, Abdelhadi S. Angioedema and urticaria in a COVID‐19 patient: A case report and review of the literature. JAAD Case Rep. 2020;6(10):1091‐1094. 10.1016/j.jdcr.2020.07.042
    1. Hassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS‐CoV‐2 (COVID‐19) infection. BMJ Case Rep. 2020;13(7):e236981. 10.1136/bcr-2020-236981
    1. Joob B, Wiwanitkit V. COVID‐19 can present with a rash and be mistaken for Dengue. J Am Acad Dermatol. 2020;82(5):e177. 10.1016/j.jaad.2020.03.036
    1. Wollina U. Schamberg‐like purpuric eruptions and tonsillitis in mild COVID‐19. Dermatol Ther. 2020:e13766. 10.1111/dth.13766
    1. Diaz‐Guimaraens B, Dominguez‐Santas M, Suarez‐Valle A, et al. Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020;156(7):820. 10.1001/jamadermatol.2020.1741
    1. Bouaziz JD, Duong T, Jachiet M, et al. Vascular skin symptoms in COVID‐19: a French observational study. J Eur Acad Dermatol Venereol JEADV. 2020;34(9). 10.1111/jdv.16544
    1. Bosch‐Amate X, Giavedoni P, Podlipnik S, et al. Retiform purpura as a dermatological sign of covid‐19 coagulopathy. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16689
    1. Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID‐19: Transient livedo reticularis. J Am Acad Dermatol. 2020;83(2):700. 10.1016/j.jaad.2020.04.018
    1. Casas CG, Català A, Hernández GC, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71‐77. 10.1111/bjd.19163
    1. Fernandez‐Nieto D, Ortega‐Quijano D, Segurado‐Miravalles G, Pindado‐Ortega C, Prieto‐Barrios M, Jimenez‐Cauhe J. Comment on: Cutaneous manifestations in COVID‐19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16470
    1. Amatore F, Macagno N, Mailhe M, et al. SARS‐CoV‐2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol JEADV. 2020. 10.1111/jdv.16528
    1. Jimenez‐Cauhe J, Ortega‐Quijano D, Carretero‐Barrio I, et al. Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings. Clin Exp Dermatol. 2020;45(7):892‐895. 10.1111/ced.14281
    1. Gargiulo L, Pavia G, Facheris P, et al. A fatal case of COVID‐19 infection presenting with an erythema multiforme‐like eruption and fever. Dermatol Ther. 2020:e13779. 10.1111/dth.13779
    1. Labé P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children. J Eur Acad Dermatol Venereol JEADV. 2020;34(10). 10.1111/jdv.16666
    1. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection. J Eur Acad Dermatol Venereol JEADV. 2020;34(9). 10.1111/jdv.16579
    1. Veraldi S, Spigariolo CB. Pityriasis rosea and COVID‐19. J Med Virol. 2021;93(7):4068. 10.1002/jmv.26679
    1. Veraldi S, Romagnuolo M, Benzecry V. Pityriasis rosea‐like eruption revealing COVID‐19. Australas J Dermatol. 2021;62(2). 10.1111/ajd.13504
    1. Johansen M, Chisolm SS, Aspey LD, Brahmbhatt M. Pityriasis Rosea in Otherwise Asymptomatic Confirmed COVID‐19 Positive Patients: A Report of Two Cases. JAAD Case Rep. 2020. 10.1016/j.jdcr.2020.10.035
    1. Martín Enguix D, Salazar Nievas MDC, Martín Romero DT. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID‐19. Med Clin Engl Ed. 2020;155(6):273. 10.1016/j.medcle.2020.05.017
    1. Stefaniak AA, Białynicki‐Birula R, Krajewski PK, Matusiak Ł, Goldust M, Szepietowski JC. Itch in the era of COVID‐19 pandemic: An unfolding scenario. Dermatol Ther. 2020;33(5):e13477. 10.1111/dth.13477
    1. García‐Salido A, de Carlos Vicente JC , Belda Hofheinz S, et al. Severe manifestations of SARS‐CoV‐2 in children and adolescents: from COVID‐19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care Lond Engl. 2020;24(1):666. 10.1186/s13054-020-03332-4
    1. Rekhtman S, Tannenbaum R, Strunk A, Birabaharan M, Wright S, Garg A. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID‐19 and multisystem inflammatory syndrome in children. J Am Acad Dermatol. 2021;84(2):408‐414. 10.1016/j.jaad.2020.10.060
    1. Aronoff SC, Hall A, Del Vecchio MT. The Natural History of SARS‐Cov‐2 Related Multisystem Inflammatory Syndrome in Children (MIS‐C): A Systematic Review. J Pediatr Infect Dis Soc. 2020. 10.1093/jpids/piaa112
    1. Malangu B, Quintero JA, Capitle EM. Adult Inflammatory Multi‐System Syndrome Mimicking Kawasaki Disease in a Patient With COVID‐19. Cureus. 2020;12(11):e11750. 10.7759/cureus.11750
    1. Riollano‐Cruz M, Akkoyun E, Briceno‐Brito E, et al. Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience. J Med Virol. 2021;93(1):424‐433. 10.1002/jmv.26224
    1. Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID‐19 infection. Dermatol Ther. 2021;34(2):e14761. 10.1111/dth.14761
    1. Moreno‐Arrones OM, Lobato‐Berezo A, Gomez‐Zubiaur A, et al. SARS‐CoV‐2‐induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol JEADV. 2021;35(3). 10.1111/jdv.17045
    1. Shanshal M. COVID‐19 related anagen effluvium. J Dermatol Treat. 2020;1‐2. 10.1080/09546634.2020.1792400
    1. Wambier CG, Vaño‐Galván S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID‐19: The “Gabrin sign”. J Am Acad Dermatol. 2020;83(2):680‐682. 10.1016/j.jaad.2020.05.079
    1. Müller Ramos P, Ianhez M, Amante MH. Alopecia and grey hair are associated with COVID‐19 Severity. Exp Dermatol. 2020;29(12):1250‐1252. 10.1111/exd.14220
    1. Goren A, Vaño‐Galván S, Wambier CG, et al. A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain ‐ A potential clue to the role of androgens in COVID‐19 severity. J Cosmet Dermatol. 2020;19(7):1545‐1547. 10.1111/jocd.13443
    1. Battista RA, Ferraro M, Piccioni LO, Malzanni GE, Bussi M. Personal Protective Equipment (PPE) in COVID 19 Pandemic: Related Symptoms and Adverse Reactions in Healthcare Workers and General Population. J Occup Environ Med. 2021;63(2):e80‐e85. 10.1097/JOM.0000000000002100
    1. Lan J, Song Z, Miao X, et al. Skin damage among health care workers managing coronavirus disease‐2019. J Am Acad Dermatol. 2020;82(5):1215‐1216. 10.1016/j.jaad.2020.03.014
    1. Krajewski PK, Matusiak Ł, Szepietowska M, Białynicki‐Birula R, Szepietowski JC. Increased Prevalence of Face Mask‐Induced Itch in Health Care Workers. Biology. 2020;9(12):451. 10.3390/biology9120451
    1. Bhatia R, Sindhuja T, Bhatia S, et al. Iatrogenic dermatitis in times of COVID‐19: A pandemic within a pandemic. J Eur Acad Dermatol Venereol JEADV. 2020;34(10). 10.1111/jdv.16710
    1. Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S. Skin Reactions to Non‐glove Personal Protective Equipment: An Emerging Issue in the COVID‐19 Pandemic. J Eur Acad Dermatol Venereol JEADV. 2020;34(7). 10.1111/jdv.16492
    1. Yan Y, Chen H, Chen L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health‐care workers fighting against coronavirus disease 2019. Dermatol Ther. 2020;33(4):e13310. 10.1111/dth.13310
    1. Anedda J, Ferreli C, Rongioletti F, Atzori L. Changing gears: Medical gloves in the era of coronavirus disease 2019 pandemic. Clin Dermatol. 2020;38(6):734‐736. 10.1016/j.clindermatol.2020.08.003
    1. Wollina U. Challenges of COVID‐19 pandemic for dermatology. Dermatol Ther. 2020;33(5):e13430. 10.1111/dth.13430
    1. Lin P, Zhu S, Huang Y, et al. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol. 2020;183(1):190‐192. 10.1111/bjd.19089
    1. Park S‐R, Han J, Yeon YM, Kang NY, Kim E. Effect of face mask on skin characteristics changes during the COVID‐19 pandemic. Skin Res Technol. 2020. 10.1111/srt.12983
    1. Alluhayyan OB, Alshahri BK, Farhat AM, et al. Occupational‐related contact dermatitis: prevalence and risk factors among healthcare workers in the Al’Qassim region, Saudi Arabia during the COVID‐19 pandemic. Cureus. 2020;12(10):e10975. 10.7759/cureus.10975
    1. Fernandez‐Nieto D, Jimenez‐Cauhe J, Suarez‐Valle A, et al. Characterization of acute acro‐ischemic lesions in non‐hospitalized patients: a case series of 132 patients during the COVID‐19 outbreak. J Am Acad Dermatol. 2020. 10.1016/j.jaad.2020.04.093
    1. Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM. The red half‐moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatol Venereol JEADV. 2020;34(11):e663‐e665. 10.1111/jdv.16747
    1. Cavanagh G, Wambier C. Rational hand hygiene during COVID‐19 pandemic. J Am Acad Dermatol. 2020. 10.1016/j.jaad.2020.03.090
    1. Elston DM. Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID‐19) epidemic. J Am Acad Dermatol. 2020. 10.1016/j.jaad.2020.03.012
    1. Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246‐e247. 10.1111/jdv.16471
    1. Fernandez‐Nieto D, Jimenez‐Cauhe J, Ortega‐Quijano D, Diaz‐Guimaraens B, Dominguez‐Santas M, Martinez‐Rubio J. Transverse leukonychia (Mees’ lines) nail alterations in a COVID‐19 patient. Dermatol Ther. 2020;33(6):e13863. 10.1111/dth.13863
    1. Ide S, Morioka S, Inada M, Ohmagari N. Beau’s Lines and Leukonychia in a COVID‐19 Patient. Intern Med Tokyo Jpn. 2020;59(24):3259. 10.2169/internalmedicine.6112-20
    1. Alobaida S, Lam JM. Beau lines associated with COVID‐19. CMAJ. 2020;192(36):E1040. 10.1503/cmaj.201619
    1. Senturk N, Ozdemir H. Onychomadesis following COVID‐19 infection: Is there a relationship? Dermatol Ther. 2020;33(6):e14309. 10.1111/dth.14309
    1. Méndez‐Flores S, Zaladonis A, Valdes‐Rodriguez R. COVID‐19 and nail manifestation: be on the lookout for the red half‐moon nail sign. Int J Dermatol. 2020;59(11):1414. 10.1111/ijd.15167
    1. Tammaro A, Adebanjo GAR, Erasmus H‐P, et al. Transverse orange nail lesions following SARS‐CoV‐2 infection. Dermatol Ther. 2020:e14688. 10.1111/dth.14688

Source: PubMed

3
Iratkozz fel